Amphetamine Drug Market Size & Share, by Application (ADHD, Narcolepsy, Obesity, Depression); Demography (Adults, Children); Distribution Channel (Retail Pharmacy, Hospital Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2527
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Amphetamine Drug Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

The amphetamine drug market is thriving on the back of increased research and development activities with the simultaneous approval of drugs.  Additionally, the surge in central nervous system disorders, sleeping disorders, and depression cases along with a shift in consumer awareness regarding mental health is also expected to play a crucial role in driving the market growth. The rising number of people suffering from various disorders has caught the attention of governments around the world, forcing them to support the ADHD drug market to address this condition. Government approvals and commercialization of drugs by market players are some of the major factors that are anticipated to drive the growth of the market during the forecast period.


Amphetamine-Drug-Market
Get more information on this report: Request Free Sample PDF

Amphetamine Drug Sector: Growth Drivers and Challenges

Growth Drivers

  • The rising number of ADHD patients globally
    According to the survey done by the Centers for Disease Control and Prevention (CDC) in 2016, 0.388 million children aged 2–5 years, 4 million children aged 6–11 years, and 3 million children aged 12–17 years were diagnosed with ADHD in the United States.

    Rising incidences of ADHD across the globe can be attributed to the low threshold of diagnostic criteria. The number of ADHD patients is rising at an alarming rate, as there is no established treatment for this disorder except for long medication procedures. Pharmacological treatments through CNS stimulants such as amphetamine are the most appropriate way to treat ADHD patients. Such factors are expected to fuel revenue growth of the global amphetamine drug market.
  • Continuous Innovation by ADHD drug manufacturers
    Market key players are continuously focusing on both, ADHD children and adults. For children, drugs are being manufactured with innovative ideas such as introducing fruit-flavors pills for easy consumption, while for adults, the focus is on reducing their daily dose by providing those doses with long-lasting effects. The packaging is another area of innovation, where blister packs are introduced instead of bottles to facilitate quick and convenient use. Manufacturers are also focusing on offering products, comparatively at lower costs. This factor is anticipated to increase the demand for amphetamine drugs in the coming years.

Challenges

  • Adverse effects associated with amphetamine drugs
    Amphetamine generally involves larger and longer doses, which can develop some greater risk to the quality of a patient’s life. There are physical and psychological effects of this drug. The physical effects consist of cardiovascular side effects, gastrointestinal side effects, and other physical side effects such as blurred vision, nose bleeding, dry mouth, and others. Whereas, psychological side effects contain apprehension, mood swings, insomnia, wakefulness, and others. A large number of contraindications and side-effects associated with amphetamine drugs are limiting prescriptions based on the therapeutic condition of patients. Despite all the advantages, contraindications and side-effects associated with amphetamine drugs are hampering the life of patients, which is estimated to restrict the growth of the amphetamine drugs market over the forecast period.

Amphetamine Drug Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Amphetamine Drug Segmentation

The amphetamine drug market is segmented by application, by demography, by distribution channel, and by region. Based on the application, the amphetamine drug market is segmented into ADHD, narcolepsy, obesity, depression, and others. Out of these, the depression segment is anticipated to dominate the market owing to the increase in the prevalence of depression among adults and children around the world. On the basis of demographics, the amphetamine drug market has been bifurcated into children and adults. Among the demographic segment, the adult segment is anticipated to hold the largest share in the market which can be attributed to a large adult patient population.

Our in-depth analysis of the global market includes the following segments

By Application Type

  • ADHD
  • Narcolepsy
  • Obesity
  • Depression
  • Others

By Demography Type

  • Adult
  • Children

By Distribution Channel Type

  • Retail Pharmacy
  • Hospital Pharmacy

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Amphetamine Drug Industry - Regional Synopsis

On the basis of regional analysis, the global amphetamine drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America industry is predicted to dominate majority revenue share by 2036, due to presence of higher number of depression and ADHD patients. Additionally, collaborations among market key players to increase market penetration for product development and effortless commercialization of the product. Such factors are anticipated to boost the market growth of the region are estimated to bring in more revenues in the market. The second-largest market share is anticipated to be held by the market in Europe owing to the presence of massive pharmaceutical companies along with increasing awareness about mental health in the region. The market in Asia Pacific region is expected to expand at a higher rate during the forecast period owing to the upsurge in the demand for drugs for the treatment of various disorders problems such as ADHD.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Amphetamine Drug Landscape

    • Teva Pharmaceutical Industries Ltd. 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Novartis AG
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • Mallinckrodt Company
    • Johnson & Johnson Services, Inc.
    • Hisamitsu Pharmaceutical Co., Inc.
    • Purdue Pharma L.P.

In the News

April 30, 2020: A joint operation run by Saudi Customs and the General Directorate of Narcotics Control claimed to seize 44.7 million amphetamine pills smuggled in Mate packets (green tea packets popular in Syria) at Al-Batha Port and King Abdullah Port in Rabigh. The growing use of amphetamine drugs illegally is being strictly controlled globally.

Author Credits:  Radhika Pawar


  • Report ID: 2527
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Amphetamine Drug Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

Amphetamine Drug Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2024-2036.

North America industry is predicted to dominate majority revenue share by 2036, due to presence of higher number of depression and ADHD patients.

The major players in the market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc, Mallinckrodt Company, Johnson & Johnson Services, Inc., Hisamitsu Pharmaceutical Co., Inc., Purdue Pharma L.P., and others.
Amphetamine Drug Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample